Positioning Creatine in a Semaglutide World
By Blaise Collins, PhD, ACSM-EP-C | Monthly Blog Contributor, Jenerise | Medical & Scientific Director | Neurology, Oncology, Hematology | Exercise Physiologist
Can you supplement with Creatine while taking Semaglutide?
The simple answer is yes. While specific clinical trials combining the two are currently in development, the biological rationale is potent. Semaglutide (GLP-1) is a revolutionary weight-loss tool, but it often leads to a significant loss of lean body mass (LBM), with estimates ranging from 10% to 50% of total weight lost being metabolically active muscle. Supplementing with Creatine Monohydrate acts as a metabolic insurance policy, helping to preserve muscle tissue, maintain your metabolic rate, and protect strength during rapid weight loss.
Creatine monohydrate (CM) has 40 years of research supporting the molecule, but is still not utilized consistently outside of active and trained populations. CM is important, as it readily gives up phosphates, which are then used for immediate ATP production within the ATP-PCr cycle. Across the literature, supplementation of CM consistently leads to increases in lean body mass and fat-free mass, and a reduction in body fat percentage, and these outcomes are further improved when resistance training is added.
Semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist which improves glycemic control, is a new (and controversial) player in the health and wellness population, popularized by its robust effect on weight. While the efficacy and safety of GLP-1 treatments have been assessed and are covered elsewhere, there still exists a very significant unmet need with the therapy. GLP-1 treatments do result in substantial decreases in body weight, which is good for cardiovascular health, joint health, quality of life, and many other outcomes and risk factors. However, not all of that body weight is fat.
With GLP-1s, there is a recurring theme of wanting to see more data around lean body mass (LBM) preservation. It’s difficult to place an estimate due to methodological differences, but estimates range from 10% to 50% of total weight loss being metabolically active lean mass. Patients receiving GLP-1 treatments are advised to exercise, and in those settings, the amount of LBM loss is reduced, but it still appears the LBM response is a feature of the treatment. This loss is concerning, as the decrease in metabolically active tissue leads to detriments in metabolism, strength and endurance, immune function, bone density, hormonal balance, and can increase the risk for injury.
GLP-1 treatments are not meant to be a long-term therapy, but rather a “bridge” to allow patients to become more active, meaning we should be focusing on maximizing LBM retention to maintain long-term metabolic effects once treatment is stopped. CM has been shown to improve LBM, an effect that is enhanced with the addition of resistance training. Additionally, creatine saturation studies show a smaller decrease in LBM during caloric restriction, which suggests a protective effect.
Currently, there are no clinical trials registered that are investigating CM as an add-on to GLP-1s. However, given the established efficacy and safety profile of both, and the potential of CM plus resistance training to address the LBM loss of GLP-1 treatments, one could speculate this to be a potent combination.
Frequently Asked Questions about Creatine & GLP-1 Resilience
1. Why is muscle loss a concern when taking Semaglutide or Wegovy?
While GLP-1 medications are effective for cardiovascular and joint health, they do not discriminate between fat and muscle loss. Losing up to 50% of your weight from lean mass can lead to a "metabolic crash," reduced immune function, and a higher risk of injury.
2. How does Creatine help prevent "Ozempic Muscle"?
Creatine monohydrate is the most researched molecule for muscle preservation. It supports the ATP-PCr cycle, providing the energy needed for muscle cells to remain active even during caloric restriction. When combined with resistance training, it is the gold standard for maximizing lean body mass retention.
3. Is it safe to mix Creatine with weight-loss medications?
Both Creatine Monohydrate and GLP-1 receptor agonists have well-established safety and efficacy profiles independently. Because they work on different biological pathways: one on appetite and blood sugar, the other on cellular energy, they are considered a strategic and safe combination for metabolic health.
4. Will supplementing with Creatine stop me from losing weight on Semaglutide?
No. While Creatine may cause slight water retention inside the muscle cells (which is a sign of healthy hydration), it does not increase body fat. In fact, by preserving muscle tissue, Creatine helps maintain a higher resting metabolic rate, making it easier to keep the weight off long-term.
5. Do I need to exercise for the Creatine and Semaglutide combo to work?
Exercise, specifically resistance training, is highly recommended for anyone on GLP-1 therapy to reduce the loss of lean mass. Creatine significantly enhances the results of that exercise, ensuring that the work you do in the gym translates into actual muscle preservation.
We all rise together,
Blaise
Note: This article is entirely speculative, comparing the MOAs of creatine and semaglutide and looking at it as how creatine can synergize, rather than compete.
